Optima Medical Competitors

Delisted . USA . 
Stock . Optima Medical Innovations
TOKIFDelisted Stock  USD 0.0001  0.00  0.00%   
The company classifies itself in the Medical Care Facilities industry (Healthcare sector). Optima Medical is often compared with VITA 34, Pacific Edge, SomnoMed, Lumos Diagnostics, and Orexo AB and additional peers. The list provides context for competitive positioning. Peer comparison shows whether Optima Medical is priced in line with similar stocks.

Optima Medical and Senzime AB Correlation View

Specify up to 10 symbols:
The mean reversion principle applied to Optima Medical's suggests that neither prolonged outperformance nor underperformance is permanent. Investors exploit this by positioning against extremes in price relative to fundamental value.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000850.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Peer comparison enriches Optima Medical analysis by revealing how the company ranks against competitors on key metrics. This relative perspective often changes investment conclusions drawn from standalone fundamental analysis.

Optima Medical Competition Correlation Matrix

Correlation analysis between Optima Medical Innovations and its competitors helps investors understand whether diversification is real or only superficial inside the same peer group. A reading near +1 usually means prices have moved in tandem, a reading near -1 suggests opposite movement, and a reading near zero points to weaker historical dependence.

High positive correlations

SHIEF
+ 0.86
ORXOF
ORXOF
+ 0.82
SOMNF
SHIEF
+ 0.82
SOMNF
ORXOF
+ 0.78
CORBF
SHIEF
+ 0.76
CORBF
SNZZF
+ 0.74
SHIEF
  

High negative correlations

GRUSF
- 0.66
PFGTF
MSCLF
- 0.38
GRUSF
SNZZF
- 0.18
PFGTF
GRUSF
- 0.16
LDXHF
GRUSF
- 0.14
SOMNF
SNZZF
- 0.08
LDXHF

Risk-Adjusted Indicators

There is a big difference between Optima Pink Sheet performing well and Optima Medical Company doing well as a business compared to the competition. Risk-adjusted metrics allow investors to compare Optima Medical's efficiency and downside exposure against peers in a more meaningful way. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Optima Medical Competitive Analysis

How does Optima Medical measure up against VITA 34, Pacific Edge, and SomnoMed? The financials tell a nuanced story. Optima Medical operates at a 1.8 M scale with 4.6 M flowing through the income statement. Optima Medical currently operates at a -18.81% net margin with return on equity at -10.39%, reflecting headwinds in the current cycle. Market capitalization diverges sharply here: 110.5 M versus 1.8 M, giving VITA 34 a clear size advantage. Optima Medical keeps more of each revenue dollar with a -18.81% margin versus -129.70% at Pacific Edge. Revenue tilts toward SomnoMed at 72.6 M compared with 4.6 M.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
TOKIF VTIAF PFGTF CORBF SOMNF LDXHF ORXOF SHIEF GRUSF MSCLF
 0.00 
0.0001
Optima
 0.00 
6.38
VITA
 0.00 
0.23
Pacific
 10.53 
1.05
Global
 0.00 
0.51
SomnoMed
 5.00 
0.21
Lumos
 0.00 
3.23
Orexo
 0.00 
0.14
Shield
 6.67 
0.32
Grown
 7.87 
7.37
Satellos
Market Volatility
(90 Days Market Risk)
Very Low
Very Low
Stable
Unknown
High
Stable
Low
Stable
Stable
Elevated
Market Performance
(90 Days Performance)
Weak
Weak
Moderate
Balanced
Moderate
Mild
Moderate
Moderate
Weak
Contained
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Small
Low
Unknown
Low
Strong
Small
Moderate
Low
High
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Analysis
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Hold
Strong Sell
Buy
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
0.06
0.79
18.43
N/A
1.27
1.05
2.05
2.6
1.61
1.04
Net Asset
7.22 M
177.95 M
115.28 M
N/A
58.09 M
36.94 M
1.27 B
44.41 M
14.21 M
12.59 M
Profit Margin
-0.19
-0.18
-1.3
N/A
-0.0611
N/A
-0.28
N/A
0.0557
N/A
EBITDA
-2.75 M
985 K
-21.8 M
N/A
524.53 K
-42.73 M
-141.3 M
-17.35 M
-193.65 K
-4.49 M
Operating Margin
0.0929
-0.15
-1.56
N/A
-0.0569
-2.31
N/A
-7.83
0.2
N/A
Current Valuation
1.59 M
146.63 M
184.47 M
N/A
62.24 M
6.33 M
76.98 M
18.31 M
21.02 M
7.17 M
Price To Book
0.0915
3.67
3.73
N/A
4.09
0.53
2.02
0.75
3.47
1.1
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
907 M
N/A
N/A
N/A
Beta
2.52
0.79
0.87
N/A
1.04
N/A
0.72
1.1
0.51
N/A
Number Of Employees
17
775
100
N/A
18
10
126
15
11
7
Shares Outstanding
50.65 M
15.83 M
810.18 M
N/A
78.56 M
222.02 M
34.35 M
585.67 M
170.63 M
41.8 M
Cash Flow From Operations
-304.4 K
2.73 M
-17.55 M
N/A
1.86 M
-18.04 M
-229 M
-16.74 M
-238.46 K
-5.03 M
Total Debt
57.08 K
10.93 M
1.92 M
N/A
2.01 M
7.19 M
492.3 M
156 K
1.37 M
N/A
Return On Equity
-0.1
-0.37
-0.22
N/A
-0.15
-1.2
-0.65
-0.57
0.26
-0.86
Z Score
18.6
6.0
77.4
N/A
22.0
-2.1
N/A
N/A
8.4
N/A
Return On Asset
0.009
-0.0503
-0.15
N/A
-0.0452
-0.25
-0.0965
-0.34
0.15
-0.4
Book Value Per Share
0.062
2.25
0.12
N/A
0.34
0.085
1.07
0.15
0.043
0.2
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
303 M
N/A
N/A
N/A
Total Asset
7.22 M
177.95 M
115.28 M
N/A
58.09 M
36.94 M
1.27 B
44.41 M
14.21 M
12.59 M
Debt To Equity
0.41
0.84
0.017
N/A
0.43
0.4
1.76
0.003
0.53
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.54
N/A
Shares Owned By Institutions
0.65
15.38
29.21
N/A
51.32
21.45
42.78
13.58
16.71
14.41
Market Capitalization
1.78 M
110.48 M
248.38 M
N/A
71.36 M
14.54 M
58.7 M
51.48 M
20.48 M
15.29 M
Price To Earning
N/A
51.47
N/A
N/A
5.61
N/A
58.66
N/A
N/A
N/A
Price To Sales
0.92
2.18
15.54
N/A
1.06
0.81
0.99
7.37
1.01
295.34
Net Income
-3.96 M
-3.67 M
-19.79 M
N/A
-4.44 M
-45.72 M
-223.5 M
-19.34 M
-1.01 M
-15.51 M
Earnings Per Share
-0.007
0.07
-0.016
N/A
-0.041
-0.15
N/A
-0.11
-0.013
-0.46
Shares Owned By Insiders
19.89
67.61
7.86
N/A
30.46
45.75
17.29
42.23
22.76
9.3
Revenue
4.61 M
28.42 M
11.45 M
N/A
72.58 M
11.63 M
565 M
1.52 M
9.38 M
N/A
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
604 M
N/A
N/A
N/A
Cash And Equivalents
113
25.4 M
105.41 M
N/A
15.64 M
7.98 M
45.61 M
2.4 M
1.53 M
1.93 M
Cash Per Share
N/A
1.61
0.13
N/A
0.19
0.04
1.32
0.01
0.01
0.06
Gross Profit
1.38 M
12.44 M
6.64 M
N/A
44.28 M
1.19 M
521.7 M
539 K
6.1 M
-793.97 K
Day Typical Price
1.0E-4
6.38
0.23
1.02
0.51
0.22
3.23
0.14
0.31
7.52
Accumulation Distribution
N/A
N/A
N/A
0.0952
N/A
3134.63
N/A
N/A
0.15
0.0821
Market Facilitation Index
N/A
N/A
N/A
0.1
N/A
0.0
N/A
N/A
0.05
0.65
Daily Balance Of Power
0.0
0.0
0.0
1.0
0.0
0.3333
0.0
0.0
0.4
-0.97
Period Momentum Indicator
N/A
N/A
N/A
0.1
N/A
0.01
N/A
N/A
0.02
-0.63
Rate Of Daily Change
1.0
1.0
1.0
1.11
1.0
1.05
1.0
1.0
1.07
0.92
Day Median Price
1.0E-4
6.38
0.23
1.0
0.51
0.22
3.23
0.14
0.31
7.6
Price Action Indicator
N/A
N/A
N/A
0.1
N/A
-0.01
N/A
N/A
0.025
-0.54
Relative Strength Index
N/A
N/A
83.36
68.65
100.0
52.85
100.0
63.86
43.56
38.24
Coefficient Of Variation
N/A
N/A
823.2
907.6
812.4
1643.59
812.4
748.75
1858.46
1311.79
Mean Deviation
N/A
N/A
7.45
2.61
0.3244
5.63
0.1761
2.16
4.91
4.16
Jensen Alpha
N/A
N/A
2.72
0.6303
0.1623
0.5041
0.0794
0.8272
0.3612
0.4145
Total Risk Alpha
N/A
N/A
3.92
0.9417
0.2239
1.01
0.117
1.14
0.7487
0.7148
Sortino Ratio
N/A
N/A
N/A
0.0683
N/A
0.0482
N/A
N/A
0.0672
0.0839
Downside Variance
N/A
N/A
N/A
98.84
N/A
144.39
N/A
N/A
38.61
30.38
Standard Deviation
N/A
N/A
22.67
5.88
1.34
9.02
0.7264
6.18
7.19
5.66
Kurtosis
N/A
N/A
42.58
11.6
66.0
3.43
66.0
39.09
7.33
1.63
Potential Upside
N/A
N/A
N/A
10.53
N/A
18.75
N/A
7.14
8.7
10.37
Treynor Ratio
N/A
N/A
-4.68
-3.51
0.8312
-0.63
-52.95
2.93
-0.98
-2.33
Maximum Drawdown
N/A
N/A
165.49
42.46
10.87
61.9
5.9
57.62
48.44
32.63
Variance
N/A
N/A
514.08
34.56
1.79
81.36
0.5277
38.23
51.69
32.09
Market Risk Adjusted Performance
N/A
N/A
-4.67
-3.50
0.8412
-0.62
-52.94
2.94
-0.97
-2.32
Risk Adjusted Performance
N/A
N/A
0.1056
0.0957
0.1013
0.0572
0.0964
0.1142
0.0514
0.0688
Skewness
N/A
N/A
6.04
2.43
8.12
0.4356
8.12
5.53
1.77
-0.24
Semi Deviation
N/A
N/A
N/A
2.78
N/A
6.75
N/A
N/A
5.13
5.14
Information Ratio
N/A
N/A
0.1228
0.1154
0.1462
0.0643
0.1656
0.1385
0.0581
0.0817
Value At Risk
N/A
N/A
N/A
-6.25
N/A
-11.76
N/A
N/A
-10.20
-7.88
Expected Short fall
N/A
N/A
N/A
-14.99
N/A
-10.88
N/A
N/A
-6.62
-5.00
Downside Deviation
N/A
N/A
N/A
9.94
N/A
12.02
N/A
N/A
6.21
5.51
Semi Variance
N/A
N/A
N/A
7.72
N/A
45.52
N/A
N/A
26.33
26.47

Optima Medical Competition Peer Performance Charts

How to Analyze Optima Medical Against Peers

Optima Medical's peer analysis compares Optima Medical with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether Optima Medical trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where Optima Medical leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.

Peer Comparison Metrics & Methodology

EPS growth trajectory comparison for Optima Medical versus peers cuts through one-quarter earnings surprises and focuses on structural earnings expansion across periods. Relative analysis can highlight whether current pricing already reflects peer-group strengths or weaknesses. For peer comparison, Optima Medical has a market cap of 1.78 M, profit margin of -18.81%.

Inputs for Optima Medical Innovations come from periodic company reporting and market reference feeds and are mapped into a consistent schema for analysis. Some fields can appear with publication lag.

This content is curated and reviewed by:

Michael Smolkin - Member of Macroaxis Board of Directors
Last reviewed on March 12th, 2026
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY